Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults MASLD Patients (DELI_MASLD Study)

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Metabolic Dysfunction Associated Steatotic Liver DiseaseSteatotic Liver DiseaseHepatic Steatosis
Interventions
DIETARY_SUPPLEMENT

Probiotic lysate (postbiotic and metabiotc)

Each capsule contains 100 mg of cell lysate and DNA fragments of the probiotic strain L. rhamnosus DV - NRRLB-68023 in powder

DIETARY_SUPPLEMENT

Placebo

Placebo

Trial Locations (5)

79010

Danylo Halytsky Lviv National Medical University, Lviv

01601

Bogomolets National Medical University, Kyiv

Kyiv City Clinical Endocrinology Center, Kyiv

Taras Shevchenko National University of Kyiv, Kyiv

02000

Center for Innovative Medical Technologies of the National Academy of Sciences of Ukraine, Kyiv

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Taras Shevchenko National University of Kyiv

OTHER

collaborator

Danylo Halytsky Lviv National Medical University

OTHER

collaborator

Kyiv City Clinical Endocrinology Center

OTHER

collaborator

Center for Innovative Medical Technologies of the National Academy of Sciences of Ukraine

OTHER

collaborator

MirImmunoFarm

UNKNOWN

collaborator

Stellar Biotics

UNKNOWN

lead

Bogomolets National Medical University

OTHER